Abstract
BackgroundThe effectiveness of somatic neoantigen-based immunotherapy is often hindered by the limited number of mutations in tumors with low to moderate mutation burden. Focusing on microsatellite-stable colorectal cancer (CRC), this...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have